Statins-Mediated Inhibition of Rho GTPases as a Potential Tool in Anti-Tumor Therapy

Author(s): Chiara Riganti, Elisabetta Aldieri, Sophie Doublier, Amalia Bosia, Dario Ghigo

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 8 , Issue 6 , 2008

Become EABM
Become Reviewer
Call for Editor


Rho GTPases, which control processes such as cell proliferation and cytoskeleton remodeling, are often hyperexpressed in tumors. Several members, such as RhoA/B/C, must be isoprenylated to interact with their effectors. Statins, by inhibiting the synthesis of prenyl groups, may affect RhoA/B/C activity and represent a promising tool in anticancer therapy.

Keywords: Rho GTPases, cancer, isoprenylation, statins, chemotherapy

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [609 - 618]
Pages: 10
DOI: 10.2174/138955708784534436
Price: $65

Article Metrics

PDF: 5